Molecular characterisation of an attenuated GdhA - derivative of Pasteurella multocida B:2
Pasteurella multocida B:2 is an important veterinary pathogen causing fatal and acute Haemorrhagic septicaemia (HS) in bovine. The pathogen is usually commensal that resides in the submandibular region of buffaloes or cattle. Monsoon season is the outbreak season for the disease to commonly devel...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2019
|
| Online Access: | http://ethesis.upm.edu.my/id/eprint/16118/1/FBSB%202020%2025%20T.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Pasteurella multocida B:2 is an important veterinary pathogen causing fatal
and acute Haemorrhagic septicaemia (HS) in bovine. The pathogen is usually
commensal that resides in the submandibular region of buffaloes or cattle.
Monsoon season is the outbreak season for the disease to commonly develop
due to the weakening immunity of the animals. Endemic countries, particularly
Asia, routinely administer oil-adjuvant or whole-killed vaccines for disease
prevention. However, these vaccines were observed to provide short-term
protection with inadequate vaccination coverage which led to a significant
failure of the vaccination program. The live-attenuated vaccine was proposed
to overcome the limitations provided by the current vaccines. A live vaccine
candidate, P. multocida B:2 GDH7 was reported to enable protection in cattle
and buffaloes via intranasal (i.n.) administration. This potential vaccine was
also reported to be self-transmitted from the vaccinated animal to the freeranging
animal allowing wider vaccination coverage. Prior to
commercialisation, this potential vaccine requires further characterisation in
accordance with the authoritative guidelines from the World Organisation for
Animal Health (OIE). Hence, in this study, the potential vaccine strain, P.
multocida B:2 GDH7 and the virulent parent strain will be characterised
through genomic and proteomic profiling. A crucial first step was to develop a
sensitive identification test to differentiate both strains which has been
achieved by the development of a precise yet straightforward PCR method. In
genomic profiling, Repetitive Extragenic Palindromic sequence-PCR (REPPCR)
was manipulated and has demonstrated different genomic DNA band
patterns of both strains. By using several bioinformatics tools, 105 outer
membrane proteins (OMPs) were determined from the proteome of the parent
strain. About 5-10% of the OMPs determined were observed in SDS-PAGE
analysis of both strains. Some of the major OMPs especially OmpA and OmpH,
are known as prominent immunogens of P. multocida, were observed to be expressed differently between the strains. In conclusion, a reproducible PCR
detection method has been developed to differentiate both strains. Further
characterisation of these strains shows a significantly different profile through
genomic and proteomic profiling. Bioinformatics analysis had enabled
selection of four antigens for future HS vaccine development. |
|---|